Mimosamycin

Mimosamycin

SCHEMBL29884075

COC1=C(C)C(=O)c2cc(=O)n(C)c(C)c2C1=O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25A P30304 2/20 0.46
▸ CDC25B P30305 2/20 0.46
▸ CYP19A1 P11511 7/20 0.40
▸ NQO2 P16083 6/20 0.40
▸ MAPT P10636 5/20 0.36
▸ ALDH1A1 P00352 4/20 0.33
▸ CYP1A2 P05177 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ ALOX15 P16050 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ USP2 O75604 1/20 0.33
▸ DUSP3 P51452 1/20 0.33
▸ MAP2K7 O14733 1/20 0.33
▸ GMNN O75496 1/20 0.33
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL600128 0.71 CDC25A (0.52) CDC25ACDC25BMAPTALDH1A1CYP1A2
SCHEMBL8434864 0.67 CDC25A (0.61) CDC25ACDC25BMAPTALDH1A1CYP1A2
SCHEMBL10951269 0.67 PDE4B (0.42) CDC25ACDC25BMAPTALDH1A1CYP1A2
SCHEMBL9627431 0.66 CDC25A (0.65) CDC25ACDC25BMAPTALDH1A1CYP1A2
SCHEMBL9655485 0.66 CDC25A (0.64) CDC25ACDC25BMAPTALDH1A1CYP1A2
SCHEMBL9628613 0.65 CDC25A (0.62) CDC25ACDC25BMAPTALDH1A1CYP1A2
SCHEMBL30132326 0.64 CDC25A (0.52) CDC25ACDC25BMAPTALDH1A1CYP1A2
SCHEMBL3414838 0.64 CDC25B (1.00) CDC25ACDC25BMAPTALDH1A1CYP1A2
SCHEMBL30002742 0.64 CDC25B (1.00) CDC25ACDC25BMAPTALDH1A1CYP1A2
SCHEMBL9628329 0.63 ALDH1A1 (0.60) CDC25ACDC25BMAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 — — US disclosed
Send feedback